COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics to Announce Limb-Girdle Muscular Dystrophy Type 2E Data Results and Fourth Quarter and Full-Year 2018 Financial Results and Recent Corporate Developments on February 27, 2019
20/02/2019
CAMBRIDGE, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced that commencing at 8:00 a.m. Eastern Time (ET) on [...]
T2 Biosystems Announces 2018 Fourth Quarter and Full Year Financial and Operational Results Release and Conference Call Date
20/02/2019
LEXINGTON, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Intercept to Announce Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019
20/02/2019
NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Inovalon Reports Fourth Quarter and Full Year 2018 Results
20/02/2019
Full Year 2018 Highlights Full year revenue of $527.7 million, up 17% year-over-year Full year net loss of $39.2 million, resulting in net loss of $0.27 per share Full year Non-GAAP net income of $39.3 million, [...]
Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors
20/02/2019
BRISBANE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq: CUTR ) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]
Cutera Reports Fourth Quarter and Full Year 2018 Financial Results
20/02/2019
Total truSculpt® Body Sculpting Generated 32% Revenue Growth in 2018 BRISBANE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and other [...]
Achaogen Announces Closing of $15 Million Underwritten Public Offering
20/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]
HTG Molecular Announces an Amendment and Extension to its Precision Diagnostic Partnership (PDP) Two
20/02/2019
TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its second [...]
Achaogen Announces Presentations at Two Upcoming Investor Healthcare Conferences
20/02/2019
-- Leerink February 27, 2019 at 9:30 a.m. ET -- -- Cowen March 12, 2019 at 12:00 p.m. ET -- SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company [...]
ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares
20/02/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced that it intends to offer and sell, subject to market and [...]
Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019
20/02/2019
WALTHAM, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Gritstone Oncology to Present at Leerink Partners Annual Global Healthcare Conference
20/02/2019
EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]
Axiom Real-Time Metrics Awarded Multiple IWRS/RTSM Studies Using Fusion’s IWRS Module
20/02/2019
TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, has been awarded three new studies using its powerful Fusion eClinical Suite’s IWRS [...]
PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital
20/02/2019
Oslo (Norway), 20 February 2019 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1. Options exercised and [...]
Fast Company Names T2Biosystems One of the World’s Most Innovative Companies – For Battling Sepsis in Hours not Days
20/02/2019
Company ranked among Top Ten Most Innovative Companies in Biotech on annual list of organizations transforming industries and shaping society LEXINGTON, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. ( [...]
Marrone Bio Innovations Appoints Zachary Moye as Southeastern U.S. Territory Sales Manager
20/02/2019
DAVIS, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Zack Moye has [...]
Genmab 2018 Annual Report
20/02/2019
Company Announcement Copenhagen, Denmark; February 20, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2018. Below is a summary of business progress and financial performance for the [...]
Medtronic EVP & RTG President Geoff Martha to Speak at Leerink Partners Global Healthcare Conference
20/02/2019
DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 8th Annual Leerink Partners Global Healthcare Conference in New York. Geoff [...]
CCAB announces creation of new brain cancer therapeutic company, Empirica Therapeutics, as part of its strategy to advance new early-stage life sciences companies
20/02/2019
TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- The Centre for the Commercialization of Antibodies and Biologics (CCAB) today announced a license agreement with Empirica Therapeutics Inc. aimed at developing new treatments [...]

Pages